$BTCS

BTCS Inc.

No enriched coverage for $BTCS in the last 7 days.

No SEC Form 4 filings for $BTCS in the last 30 days.

Med

BTCS (NASDAQ:BTCS) Rating Lowered to Strong Sell at Wall Street Zen

Wall Street Zen has downgraded BTCS (NASDAQ:BTCS) to a "strong sell" rating, despite Weiss Ratings maintaining a "hold" and the consensus being "Hold" with an average target price of $7.00. The company reported a significant quarterly EPS miss of ($2.48) against an expected $0.01, though revenue exceeded estimates. BTCS's stock is trading around $1.31, with institutional ownership remaining low despite increased positions from large asset managers like State Street and Vanguard.